P.O. Box 2049
Wimberley, TX 78676
Contact Us

Enthusiasm for “Medicare for All” healthcare is growing throughout the American political landscape, which means the lack of universal care (something that has long made the US an outlier among wealthy nations) may be slowly ending.

Healthcare is a matter of right in every other wealthy industrialized nation, although guaranteed and administered in different ways.

In Germany, the state sets prices with heavily regulated private providers for standard treatments and medications and citizens must pay according to their income level, often with state support.

In Canada, each province is the ‘single payer’ of health services, contracting with independent providers, although with laws that discourage or prohibit private health insurance.

In the UK, the National Health Service is fully socialized and its employees are civil servants, a true single payer system. The care provided by these systems is universal, heavily regulated and funded by the state. In all, medical care is far cheaper than in the US.

The US spends more on medical care, per person and as a percentage of gross domestic product, than any other nation: costs are expected to hit 18% of American GDP next year, compared to an Organization for Economic Cooperation and Development (OECD) nation average of around 11%.

Despite this enormous expenditure, roughly 10% of American adults have no health insurance and millions more are underinsured, with medical debt the leading cause of personal bankruptcy. Nor is American healthcare yielding especially impressive results on a national scale, with life expectancy and infant mortality rates markedly worse than in peer developed nations.

Given the high cost in the US, it is no surprise that politicians and pundits have viewed universal healthcare as something the country cannot afford, an inefficient government takeover that would result in higher taxes, lower standards of care and worsening costs.

That the evidence from every other industrialized nation with universal care belies this has made little impact.

Only 36% of Americans hold valid passports, and relate no more to the example of Danish healthcare than they would to reports of bacterial life on Mars. Yet the idea is suddenly catching on.

Obamacare and its discontents

“Socializing” all healthcare was not part of the official debate on Obama’s Affordable Care Act of 2010 (Obamacare), his signature domestic legislation that reformed private health insurance markets, extended coverage to the previously uninsured without universalizing it, and left the system more deeply entrenched.

Yet the leading legislative reaction to Obamacare is not expansion but destruction.

The Republican Party, currently with control of the executive branch and both branches of the federal legislature, has approved a massive tax cut for the wealthy, paid for by revoking healthcare coverage and heavily cutting Medicaid, the federal program for the poor.

According to the Congressional Budget Office, a federal body that runs cost-benefit analysis on proposed legislation, the version of the American Health Care Act 2017 (AHCA) would immediately strip 14 million Americans of their health insurance, and by 2026, 26 million would be without coverage.

The sudden prospect of millions losing medical coverage has energized citizens - who have packed local town hall meetings with their elected members of Congress, and have been raucous, even confrontational, about healthcare.

This popular response to Obamacare’s potential destruction has gone far beyond defense of the status quo and become radical by American standards, with demands for government-run universal healthcare, often called single payer but increasingly known as Medicare For All.

“Single payer” has become our Nation’s most important policy issue because people have a dramatic fear of losing their healthcare.

A bill to establish single payer - the Expanded and Improved Medicare for All Act, HR 676 - is floating around the House of Representatives though it is far from summoning a majority.

New chapters of Physicians for a National Health Program are springing up; and that group’s detailed proposals are being published in prestigious medical journals, while more physicians, fed up with fighting insurance companies to get reimbursed, are turning to single payer.

Although universalizing healthcare is a matter of fairness and social justice, it is also, counter-intuitively, the only proven way to control healthcare costs. Savvy plutocrats, such as Berkshire Hathaway investment gurus Warren Buffett and Charlie Munger, have come to support state-run universal care, given that soaring healthcare costs drag down the competitiveness of American firms.

Taming Costs is Essential

The chief savings are in reducing the administrative costs of private insurers, which add no medical value.

A June 2016 study in the American Journal of Public Health by Adam Gaffney, Steffie Woolhandler, Marcia Angell and David U Himmelstein, all members of Physicians for a National Health Program, estimates that $500 Billion a year would be saved by this market restructuring.

Independently, the US government could follow multi-payer systems like Germany and flex its buying power to negotiate down prices of healthcare procedures, prescription drugs and medical technology, given that with Medicare and Medicaid it is overwhelmingly the largest purchaser.

Intellectual property law, properly revised, could also push down prices by limiting patents on medicines (often partly developed with publicly funded research) and allowing low-cost generic equivalents to enter the market more quickly.

Big Pharma’s profit margins are enormous, roughly twice the Fortune 500 average - evidence of cartel like privileges at the expense of patients.

Development of new drugs should ultimately pass out of the private sector with its inefficiencies and profit-seeking conflicts of interest.

As economist Dean Baker has proposed, a state-managed research institute could easily develop new drugs and sell them at cost with enormous savings: contrary to capitalist folklore, many of the 20th century’s important breakthroughs, from penicillin to the polio vaccine, were developed by state and non-profit academic researchers.

Political Barriers

The barriers to socializing medicine in the US are more political than economic, and are considerable.

Many Republican elected officials have spoken out against the idea of health insurance as collectivist and morally wrong. One Republican from Pennsylvania has declared that he shouldn’t be asked to pay towards maternity care since his family does not plan on any more children, while another Republican from Alabama has said he would make the AHCA require the sick to pay more than the healthy ‘who lead good lives’.

Despite such market Calvinism, it’s not clear how deep or enduring is this opposition to “Medicare For all” among Republican voters. In the early 1960s, Republicans and most of the medical profession militantly opposed Medicare (the American Medical Association hired Ronald Reagan to denounce the program as “communism” in radio advertisements), before the program was signed into law in 1965.

Now Medicare is very popular across the political spectrum and politically impregnable. And with both parties realigning their social bases, all bets are off.

The first step will be convincing enough Democrats, itself no easy task. While Bernie Sanders campaigned on single-payer healthcare, his victorious rival Hillary Clinton condemned it as ‘utopian’, an odd choice of words for a system that works smoothly in most other developed nations.

The close ties between donors and lobbyists from the biomedical industry and the Democratic Party can be seen in the family of Senator Joe Manchin of West Virginia and his daughter Heather Bresch, CEO of Mylan, a firm which has jacked up the price of its EpiPen (an emergency device for allergic reactions) from $100 to $600 since 2009. Manchin, of course, defended his daughter’s decision.

But even if Washington Democrats remain opposed to universal care, activity at the state level is going ahead.

For now, the big battleground for universal healthcare is California, where the upper legislative chamber on 1 June passed a non-committal Senate bill (562) calling for a single-payer state system without a specific plan to fund it.

This is the result of much activist prodding: at the state’s most recent Democratic Party convention, members of National Nurses United chanted outside the event. Although the bill was just killed off by the Democratic state assembly speaker Anthony Rendon, it had support from both lieutenant governor Gavin Newsom, likely the state’s next governor, state attorney general Xavier Becerra and many other elected officials.

Is California’s single-payer plan financially feasible in the near term? The program’s cost is estimated at $400bn, only half of which could be covered by the state’s general fund without raising the additional revenue necessary until money-saving reforms can be passed at state and federal level.

Advocates are optimistic. California is the sixth-largest economy in the world and passing single payer there will have a large ripple effect. Like most US progressive efforts, California will lead the US in joining the rest of the industrialized world in providing healthcare for its people.

California’s path to single payer will not be smooth. Even if such a measure eventually does get signed into law and state funds are found, ObamaCare legislation requires the federal government to grant a waiver for any state to set up its own publicly funded system.

Conservative commitments to federalism aside, it is far from certain that the ultraconservative director of the federal Department of Health and Human Services, former Georgia Republican congressman Tom Price, would give California a waiver.

No one expects “socialized” medicine to happen all at once and without political resistance at every level of government. But even if it takes several election cycles, what was recently a dream is suddenly a defining issue in US domestic politics, and sooner or later will be legislated into reality.

Chase Madar, Le Monde (English edition), July, 2017


Financial Links







0721-business-insider-logo full 600



n220007811458 6322

CN Logo Main373x112